# Magnesium Administration in Liver Transplantation and Reperfusion Injury

> **NCT00994981** · PHASE4 · COMPLETED · sponsor: **The Catholic University of Korea** · enrollment: 61 (actual)

## Conditions studied

- Living Donor Liver Transplantation
- Reperfusion Injury

## Interventions

- **DRUG:** magnesium
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT00994981
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2011-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994981, "Magnesium Administration in Liver Transplantation and Reperfusion Injury". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00994981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*